Metabolic markers such as leptin and adiponectin could serve as alternative indicators of the effect of ephedra on weight reduction or the treatment of metabolic disorders (Klempel and Varady, 2011; Yoon et al., 2011). This evidence concerns the gene ADIPOQ and metabolic disease.